THE INTERCONVERSION OF PURINES BY TUMORS AND THE ACTION OF ANTI-PURINES.
D000818:Animals; D000970:Antineoplastic Agents; D001224:Aspartic Acid; D001375:Azaguanine; D002247:Carbon Isotopes; D005998:Glycine; D006150:Guanine Nucleotides; D007093:Imidazoles; D008099:Liver; D008190:Lyases; D015122:Mercaptopurine; D008660:Metabolism; D051379:Mice; D009374:Neoplasms, Experimental; D009711:Nucleotides; D010600:Pharmacology; D011687:Purines; D012106:Research; D012510:Sarcoma 180; D013866:Thioguanine
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D006150:Guanine Nucleotides; D007093:Imidazoles; D009711:Nucleotides; D011687:Purines; D001224:Aspartic Acid; D015122:Mercaptopurine; D008190:Lyases; D013866:Thioguanine; D001375:Azaguanine; D005998:Glycine; C030985:purine
ANTINEOPLASTIC AGENTS; ASPARTIC ACID; AZAGUANINE; CARBON ISOTOPES; EXPERIMENTAL LAB STUDY; GLYCINE; GUANINE NUCLEOTIDES; IMIDAZOLES; LIVER; LYASES; MERCAPTOPURINE; METABOLISM; MICE; NEOPLASMS, EXPERIMENTAL; NUCLEOTIDES; PHARMACOLOGY; SARCOMA 180, CROCKER; THIOGUANINE